Pharmafile Logo
Pharmafocus logo
Advanced Search
Janssen image

Vectura and J&J shake on asthma/COPD deal

January 6, 2015
Research and Development, Sales and Marketing COPD, J&J, JJ, Janssen, asthma, johnson, rezolsta, tybost, vectura

British firm Vectura has entered an agreement with Johnson & Johnson’s pharma unit Janssen to develop therapies for asthma and …

News

Pfizer buys vaccine developer Redvax

January 6, 2015
Research and Development, Sales and Marketing Pfizer, Vaccine, cmv, herpes, redbiotec, redvax, virus

Adding to its latest string of deals Pfizer has acquired vaccine developer Redvax – the pre-clinical arm of Swiss company …

News
BMS image

BMS launches new fibrosis research collaboration

January 6, 2015
Research and Development, Sales and Marketing BMS, BMS-986020, calibr, california, fibrosis, fibrotic

Bristol-Myers Squibb is entering into an agreement with the California Institute for Biomedical Research to develop new treatments for fibrotic …

News
Valeant pharma

Valeant recalls drug used on hospitalised infants

January 6, 2015
Manufacturing and Production, Sales and Marketing Actavis, Allergan, FDA, Valeant, manufacturing, recall, ribavirin, virazole

North American drug firm Valeant Pharmaceuticals has issued a voluntary nationwide recall of Virazole due to microbial contamination. Virazole (ribavirin …

News
Ebola image

UK nurse with Ebola in ‘critical condition’

January 6, 2015
Research and Development, Sales and Marketing Africa, Ebola, GSK, Mapp, WHO, cafferky, johnson, zmapp

A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …

News
janet_valentine

MRC head joins CPRD as director

January 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MHRA, MRC, cprd, janet valentine

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced an appointment of a new director for The Clinical Practice …

Appointment
moxifloxacin

Next-generation Cempra antibiotic meets endpoints

January 5, 2015
Research and Development, Sales and Marketing Antibiotics, FDA, cempra, moxifloxacin, solitaire-oral

Cempra Pharmaceuticals has become the first company to publish results from a Phase III study completed under FDA regulations governing …

News

Pharma industry set for bumper 2015

January 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2015, FDA, bumper, harvoni, opdivo, pharma, sovaldi

Industry analysts predict 2015 will be another year of growth for the pharma, after approvals of new drugs soared to …

News
Publishing image

Medical publishing: can we rely on it?

January 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, csr, journals, medical publishing, peer, publishing, transparency

The explosive proliferation of journals suggests that medical publishing is an attractive business. But it’s not without its critics, as …

Feature
alan_schoenbart

New CFO for Echo Therapeutics

January 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing alan schoenbart, echo therapeutics

US medical device firm Echo Therapeutics has appointed Alan Schoenbart as its chief financial officer.Schoenbart who has more than 30 …

Appointment
Novo image

Novo Nordisk obesity drug gets FDA nod

December 24, 2014
Sales and Marketing FDA, Novo Nordisk, Victoza, diabetes, liraglutide, saxenda

The US Food and Drug Administration has shown Novo Nordisk’s obesity drug Saxenda the green light to aid chronic weight …

News
NHS image

NHS plans bashed over cancer and heart disease

December 24, 2014
Research and Development, Sales and Marketing Cancer, England, NHS, Simon Stevens, funding, heart

Hundreds of healthcare experts have signed an open letter to NHS chief executive Simon Stevens calling for him to scrap …

News
jonathon-kellerman

Actavis hires senior head from PwC

December 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Jonathon Kellerman, pwC

Jonathon Kellerman has joined Ireland-based speciality pharma firm Actavis as its executive vice president and global chief compliance officer.  Reporting …

Appointment
Entyvio image

NICE rejects Takeda Crohn’s disease drug

December 23, 2014
Sales and Marketing Crohn’s disease, Entyvio, NHS, NICE, Takeda, crohn's disease, vedolizumab

Takeda has seen its treatment for people with Crohn’s disease Entyvio rejected by NICE in an initial appraisal. The healthcare …

News
EMA image

EMA ramps up adaptive pathways pilot

December 23, 2014
Manufacturing and Production, Research and Development, Sales and Marketing EMA, adaptive pathways, drugs, regulator

Six medicines have been selected to move to the next stage of the EMA’s adaptive pathways pilot project, to explore …

News

New hope through Ebola vaccine trial

December 23, 2014
Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, US, marburg, uganda

A report in the Lancet medical journal has highlighted a treatment found to be well-tolerated in healthy Ugandan adults during …

News
lionel_goldfrank

New chairman for Egenix

December 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing egenix, lionel goldfrank

Lionel Goldfrank has been elected to sit on the board of the US-based biotech firm Egenix. Goldfrank is to succeed Donald …

Appointment
Zerbaxa

Cubist boosts antibiotics market presence

December 22, 2014
Sales and Marketing Antibiotics, Zerbaxa, antimicrobial resistance, bacteria, cubist, infections, infectious diseases

Cubist has followed-up its successful European approval for a new antibiotic by winning an endorsement by the US FDA. The …

News
Cyramza

Lilly to market stomach cancer drug in Europe

December 22, 2014
Sales and Marketing Eli Lilly, Europe, FDA, US, cyramza, ramucirumab, stomach cancer

Eli Lilly has been granted permission by the European Commission to market Cyramza in Europe. Lilly’s Cyramza (ramucirumab) is the …

News
Abbvie

Abbvie Hep C drug gains FDA approval

December 22, 2014
Sales and Marketing AbbVie, FDA, Gilead, Viekira Pak, dasabuvir, harvoni, hepatitis, hepatits C

Abbvie has gained sign-off for its rival treatment to challenge Gilead’s dominance of the growing market for new hepatitis C …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026